Agilent Technologies stock gains after fresh analyst target lift and regulatory filing
Agilent Technologies' stock is gaining traction due to a fresh analyst target lift, a new regulatory filing, and solid revenue and earnings from the latest quarter. The company's stock is trading in the mid-$150 range, with a mean 12-month price target of $159.21 and an optimistic target of $185. Institutional investors are showing renewed interest, with new positions being taken in the company's shares.
A5143230 Bond Profile — Key Metrics
This article provides a bond profile for Agilent Technologies, Inc.'s A5143230 bond, highlighting key metrics such as a 2.3% coupon rate and a maturity date of March 12, 2031. It details the issuer's business segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. The company, founded in 1999 and headquartered in Santa Clara, CA, focuses on application-focused solutions for various markets.
Form 8K Agilent Technologies For: 19 August By Investing.com
This article from Investing.com reports on an 8K filing by Agilent Technologies for August 19th. The content is concise, primarily serving as an announcement of the filing without providing further details within the article text itself. It also includes various financial market data and related news headlines.
Mitsubishi UFJ Trust & Banking Corp Reduces Holdings in Medtronic PLC $MDT
Mitsubishi UFJ Trust & Banking Corp significantly reduced its stake in Medtronic PLC by 9.9% in the second quarter, selling over 64,000 shares. Despite this reduction, institutional investors collectively own a large portion of Medtronic, and analysts generally maintain a "Moderate Buy" rating for the company. Medtronic reported solid quarterly revenue and earnings, increased its dividend, but faces potential legal challenges and recent insider selling.
Edmond DE Rothschild Holding S.A. Acquires New Shares in Waters Corporation $WAT
Edmond DE Rothschild Holding S.A. has acquired a new stake of 22,619 shares in Waters Corporation (NYSE:WAT), valued at approximately $8.48 million, during the second quarter. Other institutional investors have also adjusted their positions in Waters, which has seen its stock rise by 3.8%. The company recently reported strong earnings, beating consensus estimates, and analysts have issued a "Moderate Buy" rating with an average target price of $420.35.
GSA Capital Partners LLP Raises Stake in Medtronic PLC $MDT
GSA Capital Partners LLP significantly increased its stake in Medtronic PLC (NYSE:MDT) by 1,112.5% during the second quarter, bringing its total holdings to 68,541 shares valued at $5.36 million. Medtronic recently exceeded quarterly earnings and revenue expectations, and raised its quarterly dividend to $0.72 per share, offering a 3.1% yield. Analysts generally maintain a "Moderate Buy" rating with an average price target of $98.83, despite some risks such as potential legal action and continued insider selling.
Agilent Technologies (A) Gains Attention In Cannabis Testing, Is It Fully Valued?
Agilent Technologies (A) is gaining attention due to its role as a key supplier in the expanding cannabis testing services market, with recent share price gains of 19.31% in one month and 35.39% in 90 days. Despite a narrative suggesting it's 3.5% undervalued with a fair value of $161 based on recurring revenue and margin expansion, its current P/E ratio of 31x exceeds the fair ratio of 24x. Investors are encouraged to review the full picture, considering both growth prospects and risks like higher tariffs and tighter research funding.
Agilent Technologies Inc (A) Stock Up 4.7% but GF Value Says Overvalued -- GF Score: 94/100
Agilent Technologies Inc (A) stock rose 4.7% to $155.41, but GuruFocus's GF Value estimates it as 5.9% overvalued at $146.82, despite a strong GF Score of 94/100. Insider activity shows $3.3M in shares sold over the past year with no buys, suggesting a lack of insider confidence. While the company exhibits strong fundamentals in profitability and growth, the current market price combined with insider selling warrants caution for investors.
International Tower Hill Mines CEO Awarded 600,365 Restricted Stock Units
David Victor Wiens, CEO and Director of International Tower Hill Mines Ltd., was awarded 600,365 restricted stock units (RSUs) on August 17, 2026. These RSUs, which are ordinary shares, will vest in three roughly equal annual installments starting one year from the grant date, provided Wiens continues his service with the company. The transaction was reported in a statement of changes in beneficial ownership filed on August 19, 2026.
Form 8K Agilent Technologies For: 19 August By Investing.com
This article announces that Agilent Technologies filed a Form 8K on August 19. The brief report from Investing.com provides no further details about the content of the filing, only mentioning the company and the filing date. It appears to be a standard news alert about a regulatory submission.
Form 8K Agilent Technologies For: 19 August By Investing.com
This article from Investing.com announces the filing of a Form 8K by Agilent Technologies on August 19. The content is brief, primarily serving as a notification of the filing rather than providing detailed information about its contents. It appears to be a standard news alert regarding corporate financial disclosures.
IPO1 ETF Holdings List — BIVA:IPO1
This article lists the holdings of the Renaissance IPO ETF (IPO1) as of August 18, 2026. The fund's top holdings include CoreWeave, Inc. Class A, Astera Labs, Inc., ARM Holdings PLC Sponsored ADR, Reddit, Inc. Class A, and Viking Holdings Ltd, detailing their respective weights, share counts, and market values.
UMH Properties CFO Kevin S. Miller Purchases Shares Through Dividend Reinvestment Plan in August 2026
UMH Properties' EVP, CFO, and Treasurer, Kevin S. Miller, acquired 64 common shares of the company through its Dividend Reinvestment and Stock Purchase Plan on August 17, 2026. The purchase price was $15.625 per share, increasing his direct ownership to 24,105.12 common shares and 4,466.28 Preferred D shares. Additionally, Miller holds various derivative securities with exercise prices ranging from $14.36 to $18.30.
Agilent Technologies stock firms ahead of earnings as guidance and analyst targets support the outlo
Agilent Technologies stock is trading in the upper $140s ahead of its August 19, 2026 earnings release, supported by strong fiscal 2026 guidance and an average analyst target above the current share price. The company reported impressive Q2 2026 earnings, beating analyst expectations for both EPS and revenue, and provided optimistic guidance for the full fiscal year. Analysts maintain a "moderate buy" consensus with an average price target of $160.24, suggesting potential upside from current levels.
ExxonMobil price pierces pivotal resistance - Forecast today - 19-08-2026
ExxonMobil (XOM) has broken above its key resistance level of $163.65, supported by its 50-day Simple Moving Average and an ascending trendline. Despite momentum indicators showing overbought conditions, the outlook remains bullish, with a target price of $175.00. The stock's primary medium-term uptrend is stable, and it continues to generate fresh bullish signals.
Bristol Myers Squibb to build $2.3B manufacturing campus in Houston
Bristol Myers Squibb announced a $2.3 billion investment to construct a high-tech medicine manufacturing campus in Houston, Texas. This 600,000-square-foot facility will create about 500 jobs and produce small molecules, biologics, and antibody-drug conjugates, enhancing the company's domestic growth strategy. The project, supported by Texas state incentives, is part of BMS's broader plan to invest $40 billion in the U.S. by 2030, reinforcing the nation's pharmaceutical supply chain.
Agilent Technologies price tries to gather positive momentum - Forecast today - 19-08-2026
Agilent Technologies (A) is trading sideways, attempting to regain positive momentum to break above the $150.10 resistance level. The stock benefits from trading above its 50-day Simple Moving Average, which acts as dynamic support for its short-term bullish trend. Overbought conditions have eased, suggesting room for further upside, with a bullish forecast targeting $158.00 if resistance is breached.
Medtronic PLC $MDT Position Reduced by Hedeker Wealth LLC
Hedeker Wealth LLC reduced its stake in Medtronic PLC (NYSE:MDT) by 36.6% in the second quarter, selling 17,444 shares and retaining 30,282 shares valued at $2,369,000. Other institutional investors showed mixed activity, with some increasing and others reducing their positions in MDT. Insider activity includes an EVP selling over 4,000 shares, and analysts have issued a "Moderate Buy" consensus rating with a target price of $98.83.
Fifth Third Bancorp Trims Position in Medtronic PLC $MDT
Fifth Third Bancorp reduced its stake in Medtronic PLC by 26.2% in the second quarter, selling 55,387 shares and retaining 155,772 shares valued at $12.2 million. Institutional investors hold 82.06% of Medtronic, which recently reported strong quarterly revenue and adjusted earnings, exceeding analyst expectations. The company also increased its quarterly dividend and maintains a "Moderate Buy" consensus rating from analysts, despite some recent price target adjustments.
Did Illumina’s (ILMN) New Debt Deal and Credit Line Refresh Just Shift Its Investment Narrative?
Illumina recently completed a US$299.913 million bond offering and established a new US$1.00 billion revolving credit facility, replacing a prior arrangement. This financial restructuring aims to enhance the company's funding mix and balance-sheet flexibility to support future corporate needs and investment in clinical and multiomics opportunities. While these moves provide more liquidity and room to manage short-term spending, the core investment drivers, competition, and research budgets remain key factors for investors to watch.
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
Adicet Bio (ACET) has shown a strong year-to-date performance, returning 3.8% and outperforming the broader Medical sector's average of 2.1%. The company currently holds a Zacks Rank #2 (Buy), with analyst sentiment improving for its earnings outlook. While it lags slightly within its specific industry, Medical - Biomedical and Genetics, its overall sector outperformance suggests continued investor interest.
Russell Investments Group Ltd. Grows Position in Agilent Technologies, Inc. $A
Russell Investments Group Ltd. has increased its stake in Agilent Technologies, Inc. by 11.3% in the second quarter, bringing its total holdings to 749,294 shares valued at approximately $99.5 million. This move comes as Agilent Technologies reported strong quarterly earnings, beating analyst estimates with $1.49 EPS and a 10% revenue increase year-over-year. The company maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $160.24.
KBC Group NV Has $10.88 Million Stock Holdings in Agilent Technologies, Inc. $A
KBC Group NV increased its stake in Agilent Technologies, Inc. (NYSE:A) by 18.4% in the second quarter, bringing its total holdings to 81,883 shares valued at $10.88 million. Several other institutional investors also adjusted their positions in Agilent, while analysts have given the stock an average rating of "Moderate Buy" with a consensus target price of $160.24. Agilent Technologies recently reported strong earnings, exceeding analyst estimates, and declared a quarterly dividend.
Montag A & Associates Inc. Purchases 11,850 Shares of Agilent Technologies, Inc. $A
Montag A & Associates Inc. significantly increased its stake in Agilent Technologies, Inc. (NYSE:A) by 911.5% in the second quarter, acquiring an additional 11,850 shares, bringing their total holdings to 13,150 shares valued at $1,750,000. Other institutional investors also adjusted their positions in the medical research company. Agilent Technologies reported strong earnings, exceeding analyst expectations, and announced a quarterly dividend.
VCI Wealth Management LLC Buys 9,105 Shares of Agilent Technologies, Inc. $A
VCI Wealth Management LLC increased its stake in Agilent Technologies (NYSE:A) by 70.5% in the second quarter, acquiring an additional 9,105 shares, bringing its total holdings to 22,020 shares valued at $2.93 million. Agilent reported strong quarterly earnings, exceeding analyst estimates with an EPS of $1.49 and a 10% revenue increase to $1.83 billion, while reaffirming its FY 2026 EPS guidance. The company maintains a "Moderate Buy" consensus rating from analysts with an average price target of $160.24 and pays a quarterly dividend of $0.255 per share.
LFG Wealth Partners LLC Invests $1.75 Million in Agilent Technologies, Inc. $A
LFG Wealth Partners LLC recently invested $1.75 million in Agilent Technologies, Inc., acquiring 13,176 shares during the second quarter. Other institutional investors also increased their stakes in the company, which reported strong quarterly earnings and maintained its fiscal 2026 EPS guidance. Analyst sentiment for Agilent Technologies remains positive, with a "Moderate Buy" consensus and an average price target of $160.24.
111 Capital Acquires Shares of 9,431 Agilent Technologies, Inc. $A
111 Capital has acquired a new stake of 9,431 shares in Agilent Technologies, Inc. (NYSE:A) during the second quarter, valued at approximately $1.253 million. This comes as several other institutional investors also increased their holdings in the medical research company. Agilent Technologies recently reported strong Q2 earnings, beating analyst estimates, and has received a "Moderate Buy" consensus rating from analysts with an average price target of $160.24.
Principal Financial Group Inc. Sells 18,893 Shares of Agilent Technologies, Inc. $A
Principal Financial Group Inc. reduced its stake in Agilent Technologies, Inc. by 5.4%, selling 18,893 shares and retaining 332,822 shares valued at approximately $44.2 million. Other institutional investors also adjusted their positions in Agilent, which reported strong quarterly earnings and year-over-year revenue growth. The stock currently has a "Moderate Buy" consensus rating from analysts with an average price target of $160.24, and the company pays a quarterly dividend.
TD Asset Management Inc Sells 26,544 Shares of Agilent Technologies, Inc. $A
TD Asset Management Inc. reduced its stake in Agilent Technologies (NYSE:A) by 2.6% in the second quarter, selling 26,544 shares but still holding 996,884 shares valued at $132.4 million. Despite this reduction, institutional investors collectively own a significant 87.41% of the company. Analysts maintain a "Moderate Buy" rating for Agilent, with an average price target of $160.24, following strong quarterly earnings where the company beat estimates and saw a 10% year-over-year revenue increase.
Oppenheimer Asset Management Inc. Makes New Investment in Keysight Technologies Inc. $KEYS
Oppenheimer Asset Management Inc. has initiated a new investment in Keysight Technologies Inc. (NYSE:KEYS), acquiring over 34,000 shares valued at approximately $11.9 million in the second quarter. Other institutional investors have also adjusted their holdings, with overall hedge fund and institutional ownership of Keysight Technologies standing at 84.58%. Insider transactions show recent sales by company director James Cullen and SVP Ingrid A. Estrada, while analysts maintain a "Moderate Buy" rating with a consensus price target of $371.92.
Qsemble Capital Management LP Lowers Stake in Agilent Technologies, Inc. $A
Qsemble Capital Management LP significantly reduced its stake in Agilent Technologies (NYSE:A) by 77.4% in the second quarter, selling 80,925 shares and retaining 23,610 shares valued at approximately $3.14 million. Despite this reduction, Agilent Technologies reported strong quarterly earnings of $1.49 per share, surpassing consensus estimates, and saw a 10% year-over-year revenue increase to $1.83 billion. The company maintained its FY 2026 EPS guidance and continues to be rated a "Moderate Buy" by Wall Street analysts with an average price target of $160.24.
Oppenheimer Asset Management Inc. Boosts Stake in Agilent Technologies, Inc. $A
Oppenheimer Asset Management Inc. significantly increased its stake in Agilent Technologies (NYSE:A) by 75.9% in the second quarter, adding 41,794 shares and bringing its total holding to $12.9 million. This move is part of a broader trend where institutional investors and hedge funds own a substantial 87.41% of Agilent's shares. The company recently reported strong quarterly earnings and revenue that surpassed analyst expectations, and maintains a "Moderate Buy" consensus rating with an average price target of $160.24, alongside a quarterly dividend payment.
Agilent Technologies, Inc. $A Shares Acquired by Jennison Associates LLC
Jennison Associates LLC significantly increased its stake in Agilent Technologies (NYSE:A) by 81.3% in the second quarter, now owning 621,278 shares valued at $82.5 million. This comes as Agilent reported strong quarterly earnings, beating estimates with an EPS of $1.49 and a 10% revenue increase to $1.83 billion, while maintaining a "Moderate Buy" consensus rating from analysts with an average price target of $160.24.
Agilent Technologies, Inc. $A Shares Sold by Massachusetts Financial Services Co. MA
Massachusetts Financial Services Co. significantly reduced its stake in Agilent Technologies, selling 2.61 million shares, though still retaining 10.01 million shares valued at approximately $1.36 billion. Despite this sale, analysts generally maintain a "Moderate Buy" rating for Agilent, with a consensus price target of $160.24. The company has shown strong financial performance, exceeding quarterly expectations with adjusted EPS of $1.49 and revenue of $1.83 billion, marking a 10% year-over-year increase.
Milford Funds Ltd. Acquires 68,768 Shares of Waters Corporation $WAT
Milford Funds Ltd. significantly increased its stake in Waters Corporation (NYSE:WAT) by 103.1% in the second quarter, purchasing an additional 68,768 shares. The firm now holds 135,437 shares valued at $50,794,000. Institutional investors collectively own 94.01% of Waters Corporation's stock, while company insiders own 0.31%.
Agilent Technologies, Inc. $A Shares Sold by Vontobel Holding Ltd.
Vontobel Holding Ltd. decreased its stake in Agilent Technologies, Inc. (NYSE:A) by 18.7% in the second quarter, selling 8,489 shares and holding a total of 36,863 shares valued at $4.897 million. Several other institutional investors also adjusted their positions in Agilent, which currently holds a "Moderate Buy" rating from analysts with a consensus target price of $160.24. The company recently reported strong quarterly earnings, beating analyst estimates, and declared a quarterly dividend of $0.255 per share.
NewEdge Advisors LLC Sells 10,106 Shares of Agilent Technologies, Inc. $A
NewEdge Advisors LLC significantly reduced its stake in Agilent Technologies, selling 10,106 shares, though institutional interest in the company remains strong with several firms increasing their holdings. Analysts maintain a "Moderate Buy" rating for Agilent, which recently surpassed earnings and revenue expectations with 10% year-over-year revenue growth. The company also declared a quarterly dividend of $0.255 per share.
Bryn Mawr Trust Advisors LLC Invests $6.67 Million in Keysight Technologies Inc. $KEYS
Bryn Mawr Trust Advisors LLC has initiated a new position in Keysight Technologies Inc. (NYSE:KEYS), purchasing 19,058 shares valued at approximately $6.67 million during the second quarter. Keysight Technologies, a scientific and technical instruments company, reported strong earnings, beating analyst estimates with $2.87 EPS and $1.72 billion in revenue, a 31.5% year-over-year increase. The company maintains a "Moderate Buy" rating from analysts, with several firms raising their price targets, indicating continued confidence in its performance.
Agilent Technologies, Inc. $A Stock Position Decreased by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. significantly reduced its stake in Agilent Technologies (NYSE:A) by 75.3% in the second quarter, selling 31,934 shares. Despite this, other institutional investors like State Street Corp, Geode Capital Management LLC, and Morgan Stanley increased their holdings. Agilent Technologies reported strong quarterly earnings, beating analyst estimates, and maintains a "Moderate Buy" consensus rating from analysts with an average price target of $160.24.
Eurizon SLJ Capital Ltd Invests $10.13 Million in Agilent Technologies, Inc. $A
Eurizon SLJ Capital Ltd has invested $10.13 million in Agilent Technologies, acquiring 76,249 shares, making it their ninth-largest holding. Agilent Technologies reported strong quarterly earnings, surpassing analyst expectations with $1.49 EPS and $1.83 billion in revenue, and provided positive fiscal year 2026 guidance. The company holds a "Moderate Buy" consensus rating from analysts with an average price target of $160.24.
Agilent (A) Stock Looks Below Fair Value But Above Fair Value On Earnings
Agilent Technologies (A) stock shows a mixed valuation, with its Discounted Cash Flow (DCF) model suggesting it is undervalued by 16.8%, indicating potential upside. However, its P/E ratio of 29.7x, while below the industry average, is above its modeled fair P/E of 24.1x, suggesting it is overvalued based on earnings. The article concludes that the stock's future movement depends on whether investors prioritize its long-term cash generation potential or current earnings multiples.
Bruker (BRKR) Is Up 13.0% After Cutting 2026 Outlook And Expanding AI Lab Tie-Up With Atinary
Bruker (BRKR) shares rose 13.0% despite the company cutting its 2026 revenue outlook to US$3.54 billion–US$3.57 billion and reporting a net loss of US$52 million in Q2 2026. The stock's positive movement is attributed to its expanded collaboration with Atinary Technologies, which involves building AI-driven Self-Driving Labs to integrate Bruker's instruments into automated R&D workflows. This strategic move aims to leverage AI for higher-value, software- and consumables-rich workflows, despite ongoing funding challenges in academic and government research.
iA Global Asset Management Inc. Raises Stake in Waters Corporation $WAT
iA Global Asset Management Inc. significantly increased its stake in Waters Corporation ($WAT) by 825.1% in the second quarter, bringing its total holdings to 16,097 shares valued at approximately $6.04 million. Other institutional investors also adjusted their positions, with institutional investors and hedge funds now owning 94.01% of the company's stock. Waters recently exceeded quarterly earnings expectations and provided strong fiscal 2026 EPS guidance, while analysts maintain a "Moderate Buy" consensus for the stock.
J. L. Bainbridge & Co. Inc. Makes New Investment in Agilent Technologies, Inc. $A
J. L. Bainbridge & Co. Inc. recently acquired a new stake in Agilent Technologies (NYSE:A), purchasing 27,150 shares valued at approximately $3.6 million, making it their 27th largest position. Agilent Technologies reported strong quarterly earnings, beating analyst estimates with an EPS of $1.49 and revenue up 10% year-over-year. The company also announced a quarterly dividend of $0.255 per share and has a "Moderate Buy" consensus rating from analysts with an average price target of $160.24.
Summitry LLC Has $88.51 Million Position in Agilent Technologies, Inc. $A
Summitry LLC slightly reduced its stake in Agilent Technologies by 1.1% in Q2 but still holds 666,332 shares valued at $88.5 million, making it their 8th largest position. Agilent Technologies reported strong Q2 earnings, surpassing analyst expectations with $1.49 EPS and $1.83 billion in revenue, and maintained its fiscal 2026 EPS guidance. The company's stock is trading near its annual high, maintains a "Moderate Buy" consensus from analysts with a target price of $160.24, and offers a quarterly dividend.
Agilent Technologies Insiders Sell US$1.1m Of Stock, Possibly Signalling Caution
Over the last year, Agilent Technologies insiders have sold US$1.1m worth of stock, which could signal caution. While some insider buying occurred, the selling volume was higher. This activity might indicate that insiders believe the stock is fully valued or that future growth prospects are less robust.
Sivia Capital Partners LLC Makes New $1.82 Million Investment in Agilent Technologies, Inc. $A
Sivia Capital Partners LLC has made a new $1.82 million investment in Agilent Technologies, Inc., acquiring 13,689 shares. Other institutional investors like State Street Corp and Morgan Stanley also increased their stakes. Analysts maintain a "Moderate Buy" rating with an average price target of $160.24, and Agilent recently reported strong quarterly earnings and a quarterly dividend.
Louisbourg Investments Inc. Has $4.79 Million Stock Holdings in Agilent Technologies, Inc. $A
Louisbourg Investments Inc. reduced its stake in Agilent Technologies by 22.2% in the second quarter, selling 10,313 shares but still holding 36,056 shares valued at approximately $4.79 million. Despite this reduction, analysts generally maintain a "Moderate Buy" rating for Agilent, with an average price target of $160.24. Agilent recently reported strong quarterly results, exceeding EPS and revenue estimates, and offers a quarterly dividend of $0.255.
Agilent Technologies stock holds steady as earnings beat and new analyst target support valuation
Agilent Technologies (A) stock is holding steady after reporting stronger-than-expected Q2 2026 earnings per share of $1.49 and 10% revenue growth to $1.83 billion. The company also issued fiscal 2026 EPS guidance between $6.00 and $6.10, which analysts anticipate will be around $6.01. A new analyst target of $175, up from $160, and a consensus target of $160.24, suggest continued confidence in the company's financial outlook, with the stock trading near its 52-week highs.
28,409 Shares in Agilent Technologies, Inc. $A Acquired by Oak Thistle LLC
Oak Thistle LLC acquired 28,409 shares of Agilent Technologies (NYSE:A) in the second quarter, valued at approximately $3.77 million, with several other institutional investors also initiating positions. Analysts have a "Moderate Buy" consensus rating for Agilent with an average price target of $160.24, following the company's strong Q2 earnings where it beat EPS estimates and reported a 10% revenue increase. Agilent also continues to pay a quarterly dividend of $0.255 per share.
